Literature DB >> 8762581

A comparison of equid herpesvirus-1 (EHV-1) vascular lesions in the early versus late pregnant equine uterus.

K C Smith1, J A Mumford, K Lakhani.   

Abstract

Four Welsh Mountain pony mares at 3 months of gestation and one mare at 5 months were inoculated intranasally with equid herpesvirus-1 (EHV-1: Ab4 isolate) at doses of 10(5) to 10(6.6) TCID50. All five mares became infected, but no cases of paresis or abortion occurred. On days 8, 9, 11, 12 (3-month-pregnant mares) and 13 (5-month-pregnant mare) after infection, a detailed examination of the pregnant uterus was made. Small numbers of vascular lesions with EHV-1 antigen expression in endothelial cells were present in the uteri of the early gestational mares; thrombi were rare and foci of thromboischaemic damage were not seen. Six pony mares previously inoculated with EHV-1 Ab4 at 9 months of gestation had a significantly greater degree of vascular abnormality than that found in the four mares infected at 3 months of gestation, but the degree of EHV-1 antigen expression and thrombosis in the uterus was similar to that found in the single mare infected when 5 months pregnant.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8762581     DOI: 10.1016/s0021-9975(96)80045-4

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  11 in total

1.  Equine Herpesvirus Type 1 Enhances Viral Replication in CD172a+ Monocytic Cells upon Adhesion to Endothelial Cells.

Authors:  Kathlyn Laval; Herman W Favoreel; Katrien C K Poelaert; Jolien Van Cleemput; Hans J Nauwynck
Journal:  J Virol       Date:  2015-08-19       Impact factor: 5.103

2.  Glycoproteins D of equine herpesvirus type 1 (EHV-1) and EHV-4 determine cellular tropism independently of integrins.

Authors:  Walid Azab; Nikolaus Osterrieder
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

3.  Equine herpesvirus 1 entry via endocytosis is facilitated by alphaV integrins and an RSD motif in glycoprotein D.

Authors:  Gerlinde R Van de Walle; Sarah T Peters; Brian C VanderVen; Dennis J O'Callaghan; Nikolaus Osterrieder
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

4.  Equid herpesvirus type 1 activates platelets.

Authors:  Tracy Stokol; Wee Ming Yeo; Deborah Burnett; Nicole DeAngelis; Teng Huang; Nikolaus Osterrieder; James Catalfamo
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

5.  Comparative Genomic Sequencing and Pathogenic Properties of Equine Herpesvirus 1 KyA and RacL11.

Authors:  Akhalesh K Shakya; Dennis J O'Callaghan; Seong K Kim
Journal:  Front Vet Sci       Date:  2017-12-11

6.  Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity.

Authors:  Christiane L Schnabel; Christine L Wimer; Gillian Perkins; Susanna Babasyan; Heather Freer; Christina Watts; Alicia Rollins; Nikolaus Osterrieder; Bettina Wagner
Journal:  BMC Vet Res       Date:  2018-08-22       Impact factor: 2.741

7.  EHV-1 Pathogenesis: Current in vitro Models and Future Perspectives.

Authors:  Mohamed Kamel; Selvaraj Pavulraj; Klaus Osterrieder; Walid Azab
Journal:  Front Vet Sci       Date:  2019-07-31

8.  Equine herpesvirus type 1 infection induces procoagulant activity in equine monocytes.

Authors:  Wee Ming Yeo; Nikolaus Osterrieder; Tracy Stokol
Journal:  Vet Res       Date:  2013-03-11       Impact factor: 3.683

9.  Subcutaneous Administration of Low-Molecular-Weight Heparin to Horses Inhibits Ex Vivo Equine Herpesvirus Type 1-Induced Platelet Activation.

Authors:  Tracy Stokol; Priscila B S Serpa; Marjory B Brooks; Thomas Divers; Sally Ness
Journal:  Front Vet Sci       Date:  2018-05-28

10.  Outbreak of equid herpesvirus 1 abortions at the Arabian stud in Poland.

Authors:  Karol Stasiak; Magdalena Dunowska; Jerzy Rola
Journal:  BMC Vet Res       Date:  2020-10-06       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.